Tirzepatide Prescribing at MOTE
Drugs used in diabetes | Endocrine System
Items (12m)
360
Total Quantity
381
NHS Cost
£36.2K
vs National Avg
+85.4%
MOTE prescribed 360 items of Tirzepatide over the last 12 months at a cost of £36,166 to the NHS. This is 85.4% above the national average prescribing rate. Tirzepatide is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
10
Jun 2026
17
Jun 2026
16
Jun 2026
20
Jun 2026
22
Jun 2026
24
Jun 2026
24
Jun 2026
32
Jun 2026
47
Jun 2026
35
Jun 2026
50
Jun 2026
63
Prescribing Details
| Total Items | 360 |
|---|---|
| Total Quantity | 381 |
| Total NHS Cost | £36,166 |
| Presentations | 8 different forms |
| vs National Average | +85.4% |
Tirzepatide Prescribing Comparison
| This practice | 360 items |
|---|---|
| National average per practice | 194 items |
| Difference | +85.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.